American Society of Clinical Oncology

SHERPA: White

People

  1. O'Reilly
    O'Reilly
  2. Park
    Park
  3. Schultz
    Schultz
  4. Chatila
    Chatila
  5. Solit
    Solit
  6. Berger
    Berger
  7. Stadler
    Stadler
  8. Walch
    Walch
  9. Varghese
    Varghese
  10. Yu
    Yu

Groups

  1. MSK Grad Students (108)
  2. Department of Medicine (100)
  3. Solid Tumor Oncology Division (82)
  4. GSK Faculty (66)
  5. CTCR Scholars (61)
  6. Master of Science in Clinical and Translational Cancer Research (60)
  7. Gastrointestinal Oncology Service (55)
  8. Human Oncology and Pathogenesis Program (55)
  9. Center for Pancreatic Cancer Research (54)
  10. Epidemiology and Biostatistics (48)
Search Within
  1. "MSK Grad Students"
Formats
  1. Meeting Abstract (83)
  2. Journal Article (20)
  3. Correspondence (4)
  4. Editorial (1)
Groups
  1. MSK Grad Students (108)
  2. Department of Medicine (100)
  3. Solid Tumor Oncology Division (82)
  4. GSK Faculty (66)
  5. CTCR Scholars (61)
  6. Master of Science in Clinical and Translational Cancer Research (60)

More Groups

People
  1. Walid Chatila (25)
  2. Eileen O'Reilly (24)
  3. Nikolaus Schultz (24)
  4. Wungki Park (24)
  5. David Solit (21)
  6. Michael Berger (21)

More People

Years
  1. 2023 (25)
  2. 2022 (20)
  3. 2021 (11)
  4. 2020 (23)
  5. 2019 (11)
  6. 2018 (8)

More Years

Publications
  1. Journal of Clinical Oncology (98)
  2. JCO Precision Oncology (10)

Results (108)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Meeting Abstract

    Bewersdorf, J. P.; Sheth, A.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Lenis, A. T.; Chen, Z.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Acute GVHD diagnosis and adjudication in a multicenter trial: A report From the BMT CTN 1202 biorepository study
    Journal Article

    Reshef, R.; Saber, W.; Bolaños-Meade, J.; Chen, G.; Chen, Y. B.; Ho, V. T.; Ponce, D. M.; Nakamura, R.; Martens, M. J.; Hansen, J. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Prevalence and characterization of biallelic and monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population
    Journal Article

    Salo-Mullen, E. E.; Maio, A.; Mukherjee, S.; Bandlamudi, C.; Shia, J. R.; Kemel, Y.; Cadoo, K. A.; Liu, Y.; Carlo, M.; Ranganathan, M.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in Claudin 18.2-positive metastatic pancreatic cancer (mPC)
    Meeting Abstract

    Park, W.; O'Reilly, E. M.; Furuse, J.; Kunieda, F.; Jie, F.; Kindler, H. L.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Germ cell tumor molecular heterogeneity revealed through analysis of primary and metastasis pairs
    Journal Article

    Cheng, M. L.; Donoghue, M. T. A.; Audenet, F.; Wong, N. C.; Pietzak, E. J.; Bielski, C. M.; Isharwal, S.; Iyer, G.; Funt, S.; Bagrodia, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1
    Journal Article

    Kinnaman, M. D.; Hamill, D.; Yabe, M.; Powell, J.; Benhamida, J.; Hasselblatt, M.; Neumann, M.; Vokuhl, C.; Koelsche, C.; von Deimling, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save